The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Editor

Share

Personal info

View

Links

Table of contents

About

Terms

 

Christopher J. Kratochvil

Department of Psychiatry

University of Nebraska Medical Center

985581 Nebraska Medical Center

Omaha

USA

[email]@unmc.edu

Name/email consistency: high

 
 
 
 
 
 
 

Affiliation

  • Department of Psychiatry, University of Nebraska Medical Center, 985581 Nebraska Medical Center, Omaha, USA. 2001 - 2011

References

  1. A double-blind, placebo-controlled study of atomoxetine in young children with ADHD. Kratochvil, C.J., Vaughan, B.S., Stoner, J.A., Daughton, J.M., Lubberstedt, B.D., Murray, D.W., Chrisman, A.K., Faircloth, M.A., Itchon-Ramos, N.B., Kollins, S.H., Maayan, L.A., Greenhill, L.L., Kotler, L.A., Fried, J., March, J.S. Pediatrics (2011) [Pubmed]
  2. Treatment response in depressed adolescents with and without co-morbid attention-deficit/hyperactivity disorder in the Treatment for Adolescents with Depression Study. Kratochvil, C.J., May, D.E., Silva, S.G., Madaan, V., Puumala, S.E., Curry, J.F., Walkup, J., Kepley, H., Vitiello, B., March, J.S. J. Child. Adolesc. Psychopharmacol (2009) [Pubmed]
  3. Review of pediatric attention deficit/hyperactivity disorder for the general psychiatrist. Kratochvil, C.J., Vaughan, B.S., Barker, A., Corr, L., Wheeler, A., Madaan, V. Psychiatr. Clin. North Am. (2009) [Pubmed]
  4. Acute atomoxetine treatment of younger and older children with ADHD: a meta-analysis of tolerability and efficacy. Kratochvil, C.J., Milton, D.R., Vaughan, B.S., Greenhill, L.L. Child. Adolesc. Psychiatry. Ment. Health (2008) [Pubmed]
  5. A pilot study of atomoxetine in young children with attention-deficit/hyperactivity disorder. Kratochvil, C.J., Vaughan, B.S., Mayfield-Jorgensen, M.L., March, J.S., Kollins, S.H., Murray, D.W., Ravi, H., Greenhill, L.L., Kotler, L.A., Paykina, N., Biggins, P., Stoner, J. J. Child. Adolesc. Psychopharmacol (2007) [Pubmed]
  6. Emotional expression during attention-deficit/hyperactivity disorders treatment: initial assessment of treatment effects. Kratochvil, C.J., Faries, D., Vaughan, B., Perwien, A., Busner, J., Saylor, K., Kaplan, S., Buermeyer, C., Swindle, R. J. Child. Adolesc. Psychopharmacol (2007) [Pubmed]
  7. High-dose atomoxetine treatment of ADHD in youths with limited response to standard doses. Kratochvil, C.J., Michelson, D., Newcorn, J.H., Weiss, M.D., Busner, J., Moore, R.J., Ruff, D.D., Ramsey, J., Dickson, R., Turgay, A., Saylor, K.E., Luber, S., Vaughan, B., Allen, A.J. J. Am. Acad. Child. Adolesc. Psychiatry (2007) [Pubmed]
  8. Pharmacological management of preschool ADHD. Kratochvil, C.J., Egger, H., Greenhill, L.L., McGough, J.J. J. Am. Acad. Child. Adolesc. Psychiatry (2006) [Pubmed]
  9. Selecting an antidepressant for the treatment of pediatric depression. Kratochvil, C.J., Vitiello, B., Brent, D., Bostic, J.Q., Naylor, M.W. J. Am. Acad. Child. Adolesc. Psychiatry (2006) [Pubmed]
  10. Selective serotonin reuptake inhibitors in pediatric depression: is the balance between benefits and risks favorable?. Kratochvil, C.J., Vitiello, B., Walkup, J., Emslie, G., Waslick, B.D., Weller, E.B., Burke, W.J., March, J.S. J. Child. Adolesc. Psychopharmacol (2006) [Pubmed]
  11. Less is more: inpatient management of a child with complex pharmacotherapy. Kratochvil, C.J., Varley, C., Cummins, T.K., Martin, A. J. Am. Acad. Child. Adolesc. Psychiatry (2006) [Pubmed]
  12. Effects of long-term atomoxetine treatment for young children with attention-deficit/hyperactivity disorder. Kratochvil, C.J., Wilens, T.E., Greenhill, L.L., Gao, H., Baker, K.D., Feldman, P.D., Gelowitz, D.L. J. Am. Acad. Child. Adolesc. Psychiatry (2006) [Pubmed]
  13. Pharmacological management of a teen with significant alcohol use and depression. Kratochvil, C.J., Kazura, A., Deas, D., Martin, C.A., Dosh, T., Wilens, T.E. J. Am. Acad. Child. Adolesc. Psychiatry (2006) [Pubmed]
  14. Pharmacological management of a youth with ADHD, marijuana use, and mood symptoms. Kratochvil, C.J., Wilens, T.E., Upadhyaya, H. J. Am. Acad. Child. Adolesc. Psychiatry (2006) [Pubmed]
  15. Acute time to response in the Treatment for Adolescents with Depression Study (TADS). Kratochvil, C., Emslie, G., Silva, S., McNulty, S., Walkup, J., Curry, J., Reinecke, M., Vitiello, B., Rohde, P., Feeny, N., Casat, C., Pathak, S., Weller, E., May, D., Mayes, T., Robins, M., March, J. J. Am. Acad. Child. Adolesc. Psychiatry (2006) [Pubmed]
  16. Pharmacological management of treatment-resistant pediatric depression. Kratochvil, C.J., Wagner, K.D., Emslie, G., March, J. J. Am. Acad. Child. Adolesc. Psychiatry (2005) [Pubmed]
  17. Pharmacological management of treatment-induced insomnia in ADHD. Kratochvil, C.J., Lake, M., Pliszka, S.R., Walkup, J.T. J. Am. Acad. Child. Adolesc. Psychiatry (2005) [Pubmed]
  18. Pharmacological management of agitation and aggression in an adolescent with autism. Kratochvil, C.J., Findling, R.L., McDougle, C.J., Scahill, L., Hamarman, S. J. Am. Acad. Child. Adolesc. Psychiatry (2005) [Pubmed]
  19. Atomoxetine alone or combined with fluoxetine for treating ADHD with comorbid depressive or anxiety symptoms. Kratochvil, C.J., Newcorn, J.H., Arnold, L.E., Duesenberg, D., Emslie, G.J., Quintana, H., Sarkis, E.H., Wagner, K.D., Gao, H., Michelson, D., Biederman, J. J. Am. Acad. Child. Adolesc. Psychiatry (2005) [Pubmed]
  20. Pharmacological management of new-onset bipolar disorder. Kratochvil, C.J., Delbello, M., Upadhyaya, H., Wozniak, J. J. Am. Acad. Child. Adolesc. Psychiatry (2005) [Pubmed]
  21. Atomoxetine in the treatment of attention deficit hyperactivity disorder. Kratochvil, C.J., Vaughan, B.S., Daughton, J.M., Mayfield-Jorgensen, M.L., Burke, W.J. Expert. Rev. Neurother (2004) [Pubmed]
  22. Atomoxetine: a selective noradrenaline reuptake inhibitor for the treatment of attention-deficit/hyperactivity disorder. Kratochvil, C.J., Vaughan, B.S., Harrington, M.J., Burke, W.J. Expert. Opin. Pharmacother (2003) [Pubmed]
  23. Pharmacotherapy of childhood anxiety disorders. Kratochvil, C.J., Harrington, M.J., Burke, W.J., March, J.S. Curr. Psychiatry. Rep (2002) [Pubmed]
  24. An open-label trial of tomoxetine in pediatric attention deficit hyperactivity disorder. Kratochvil, C.J., Bohac, D., Harrington, M., Baker, N., May, D., Burke, W.J. J. Child. Adolesc. Psychopharmacol (2001) [Pubmed]
 
WikiGenes - Universities